ProCE Banner Activity

CE / CME

Modern Approaches to CMV Prevention in Solid Organ Transplant Recipients

Video

Hear expert faculty discuss emerging strategies for CMV prevention following solid organ transplantation, including integration of the latest data and developments in antivirals and laboratory monitoring.

Pharmacists: 1.25 contact hours (0.125 CEUs)

Physicians: Maximum of 1.25 AMA PRA Category 1 Credits

Released: November 09, 2023

Expiration: November 08, 2024

Share

Faculty

Atul Humar

Atul Humar, MD

Director of Transplantation 
Department of Medicine 
University of Toronto 
Toronto, Ontario, Canada 

Hannah Imlay

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Raymund Razonable

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Target Audience

This program is intended for infectious diseases physicians, pharmacists, and other healthcare professionals who care for patients at risk for CMV following solid organ transplantation.

Program Learning Goal

The goal of this activity is to integrate the latest scientific data and developments in antivirals and laboratory monitoring into optimized CMV management approaches in SOT recipients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply evidence-based monitoring strategies to CMV management  approaches in SOT recipients

  • Integrate emerging antiviral strategies for CMV prevention into optimized management plans for SOT recipients

  • Individualize CMV prevention strategies for SOT recipients in complex clinical scenarios including late CMV infections and secondary prophylaxis

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Atul Humar, MD

Director of Transplantation 
Department of Medicine 
University of Toronto 
Toronto, Ontario, Canada 

Atul Humar, MD: consultant/advisor/speaker: Astellas, Merck, Takeda; researcher: GSK, Merck, Qiagen; other financial material support: Eurofins-Viracor, Merck, Takeda.

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Hannah Imlay, MD, MS, has no relevant financial relationships to disclose.

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Raymund Razonable, MD: consultant/advisor/speaker: Novartis; researcher: Gilead, Regeneron, Roche; independent contractor: Allovir.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from November 09, 2023, through November 08, 2024:

1. Login or Sign Up for an account by clicking at the top of this page.
2. Read the target audience, learning objectives, and faculty disclosures.
3. View and study the content in its entirety.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.25 contact hour (0.125 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number -  JA4008176-0000-23-282-H01-P 
Type of Activity: Application

Upon successfully completing the post-test with a score of 65 or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.